BL
CRBP icon

BFSG LLC’s Corbus Pharmaceuticals CRBP Stock Holding History

BFSG LLC’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10 Hold
1
– – ﹤0.01% 748
2025
Q4 		$9 Hold
1
– – ﹤0.01% 716
2025
Q3 		$13 Hold
1
– – ﹤0.01% 703
2025
Q2 		$7 Hold
1
– – ﹤0.01% 670
2025
Q1 		$6 Hold
1
– – ﹤0.01% 674
2024
Q4 		$12 Hold
1
– – ﹤0.01% 670
2024
Q3 		$21 Hold
1
– – ﹤0.01% 638
2024
Q2 		$46 Hold
1
– – ﹤0.01% 616
2024
Q1 		$40 Sell
1
-60
-98% -$1.48K ﹤0.01% 655
2023
Q4 		$369 Buy
+61
New +$327 ﹤0.01% 588

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFSG LLC's CRBP Position: Q1 2026 in Review

BFSG LLC held its Corbus Pharmaceuticals (CRBP) position steady in Q1 2026 at 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #748.

BFSG LLC first reported a position in CRBP in Q4 2023 and has held it in 10 quarters since. The position peaked at $369 in Q4 2023. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • BFSG LLC held 1 share of Corbus Pharmaceuticals worth $10 as of Q1 2026.
  • BFSG LLC left its Corbus Pharmaceuticals share count unchanged in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of BFSG LLC's portfolio in Q1 2026, its #748 holding.
  • BFSG LLC first reported a position in Corbus Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • BFSG LLC's Corbus Pharmaceuticals position peaked at $369 in Q4 2023.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.